Category: Beovu
Do You Have WET AMD? The FDA Approves a New Drug
We are excited to offer our patients a new treatment for wet age-related macular degeneration (AMD). Last month, the FDA approved Beovu® (brolucizumab) which is a new anti-vascular endothelial growth factor (anti-VEGF) antibody that may require few injections than the existing medications already on the market. This is the first new drug approved since 2011… Read More
